Evidence map›Paper›PMID 30833319›Full record

ArticleBMJ open2019

Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England.

Andrew Sturrock, Philip M Preshaw, Catherine Hayes, Scott Wilkes

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. A qualitative analysis of dental challenges for oncology patients receiving bone-modifying agents.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  17. Antiresorptive medication in oncology: the clinical and dental profile of patients in a reference center.Journal of the Korean Association of Oral and Maxillofacial Surgeons · 2021
    Article
  18. Article
  19. Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Observational
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Andrew SturrockSchool of Pharmacy and Pharmaceutical Sciences, University of Sunderland, Sunderland, UK.ORCID 0000-0002-3316-1412
Philip M PreshawNational University Centre for Oral Health, National University of Singapore, Singapore.ORCID 0000-0002-7153-4865
Catherine HayesFaculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK.
Scott WilkesSchool of Medicine, University of Sunderland, Sunderland, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the impact of medication-related osteonecrosis of the jaw (MRONJ) on quality of life and to explore the attitudes and perceptions of patients towards the multidisciplinary approach to the prevention of the condition.

designInterpretivist methodology using qualitative semistructured interviews.

settingPrimary care general medical practices and secondary care dental services in England.

participants23 patients; 6 with MRONJ, 13 prescribed bisphosphonates, 4 with osteoporosis not currently prescribed any medication.

resultsPatients felt that MRONJ had a significant negative impact on their quality of life and had poor knowledge of the preventive strategies recommended in the literature. Patients demonstrated positive attitudes towards a multidisciplinary approach to care; however, they perceived prescribers as having the key role in articulating risk. Four salient and inter-related themes emerged from the interviews: (1) perception of knowledge, indicating limited awareness of the condition, risk factors and preventive strategies; (2) quality of life, indicating the lived experiences of patients and the physical, psychological and social impacts of MRONJ; (3) interprofessional management, indicating a perceived organisational hierarchy, professional roles and responsibilities, prioritising aspects of care, articulation of risk and communication and (4) wider context, indicating demands on National Health Service resources and barriers to dental care.

conclusionsMRONJ has a significant detrimental impact on quality of life, yet appropriate preventative education is not apparent. Effective interprofessional patient education and prevention to mitigate against the risk of developing MRONJ is required.

Indexed as

Health Knowledge, Attitudes, PracticeQuality of LifeAgedBisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsDiphosphonatesFemaleGrounded TheoryHumansMaleMiddle AgedOral HealthOsteoporosisProfessional RoleQualitative ResearchBone Density Conservation AgentsDiphosphonatesmedication-related osteonecrosis of the jaworal healthqualitative researchquality of life

Identifiers

PMID30833319
PMCPMC6443056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.